Home | Articles
Published on:August 2018
Indian Journal of Pharmaceutical Education and Research, 2018; 52(4s):s11-s15
Original Article | doi:10.5530/ijper.52.4s.70

Impact of Concomitantly Administered Curcumin on Pharmacokinetics of Daclatasvir in Mice Under the Frame of Herb-Drug Interaction


Authors and affiliation (s):

Asmita Magotra, Pankul Kotwal, Shipra Bhatt, Ashish Dogra, Gurdarshan Singh, Utpal Nandi*

PK-PD, Toxicology and Formulation Division, CSIR-Indian Institute of Integrative Medicine, Jammu, Jammu and Kashmir, INDIA.

Abstract:

Objective: Daclatasvir is a new orally acting antiviral drug for the treatment of hepatitis C virus (HCV). It is substrate of both P-glycoprotein (P-gp) and CYP3A4 which are involved in the major pharmacokinetic interaction between drug-drug or drug-food. Curcumin, a natural polyphenol extracted from Curcuma longa is used regularly and widely as food additive or dietary supplement. We surmised that curcumin may interfere with the pharmacokinetics of daclatasvir as curcumin is known to have potential to hinder the drug transporters and hepatic drug metabolising enzymes. Hence, investigations were taken up to assess for such possible interactions. Materials and Methods: Pharmacokinetics of daclatasvir after oral administration as alone and in combination with curcumin (2.5 or 5 or 10 mg/kg) were investigated in Balb/C mice following determination of daclatasvir plasma concentration by using a sensitive LC-MS/MS method. Results: Area under the plasma concentration-time curve for daclatasvir was decreased at lowest dose and increased subsequently at higher doses upon concomitant administration of curcumin with daclatasvir in comparison to daclatasvir alone. Maximum plasma concentration of daclatasvir was enhanced only at highest dose. Overall effects of curcumin on daclatasvir pharmacokinetics were not statistically significant at all dose levels except significant increase in mean residence time. Conclusion: Intensity of curcumin effect on the daclatasvir pharmacokinetics at the experimental dose level in the mice model suggests that dose adjustment is unlikely to be required. Further experimentations are needed to confirm its clinical significance.

Key words: Daclatasvir, Curcumin, Pharmacokinetic interaction, Herb-drug interaction, Food-drug interaction.

 

Articles in PDF, ePUB and Full text are attached to this page. In order to download, print or access these formats you must be logged in.
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.
2 + 18 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.




 

Impact Factor

IJPER - An Official Publication of Association of Pharmaceutical Teachers of India is pleased to announce continued growth in the 2019 Release of Journal Citation Reports (source: 2018 Web of Science Data).

 

Impact Factor® as reported in the 2018 Journal Citation Reports® (Clarivate Analytics, 2019): 0.425

User login

CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.
2 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

The Official Journal of Association of Pharmaceutical Teachers of India (APTI)
(Registered under Registration of Societies Act XXI of 1860 No. 122 of 1966-1967, Lucknow)

Indian Journal of Pharmaceutical Education and Research (IJPER) [ISSN-0019-5464] is the official journal of Association of Pharmaceutical Teachers of India (APTI) and is being published since 1967.

DOI HISTORY

IJPER uses reference linking service using Digital Object Identifiers (DOI) by Crossref. Articles from the year 2013 are being assigned DOIs for its permanent URLs